Decreased coronary vasodilatory capacity in hypertrophic cardiomyopathy determined by split-dose thallium-dipyridamole myocardial scintigraphy

This publication has 29 references indexed in Scilit:

• Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography.
  Circulation, 1987
• Limited coronary flow reserve after dipyridamole in patients with ergonovine-induced coronary vasoconstriction.
  Circulation, 1987
• Relationship of exercise or pacing induced ST segment depression and myocardial lactate metabolism in patients with hypertrophic cardiomyopathy.
  Japanese Heart Journal, 1986
• Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures.
  Circulation, 1985
• Split dose thallium-201 dipyridamole imaging: A new technique for obtaining thallium images before and immediately after an intervention
  Journal of the American College of Cardiology, 1983
• Pathophysiology of chest pain in patients with cardiomyopathies and normal coronary arteries.
  Circulation, 1982
• Reduced coronary dilatory capacity and ultrastructural changes of the myocardium in patients with angina pectoris but normal coronary arteriograms.
  Circulation, 1981
• Effects of propranolol on myocardial oxygen consumption, substrate extraction, and haemodynamics in hypertrophic obstructive cardiomyopathy.
  Heart, 1980
• Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologie coronary vasodilatation
  The American Journal of Cardiology, 1978
• Effects of Persantin (RA8), A New Coronary Vasodilator, on Coronary Blood Flow and Cardiac Dynamics in the Dog
  Circulation Research, 1962